AbbVie Inc.ABBVNYSE
Loading
Net Income ContractionContracting
Percentile Rank21
3Y CAGR-29.1%
5Y CAGR-1.7%
Year-over-Year Change
Total earnings after all expenses, taxes, and interest
3Y CAGR
-29.1%/yr
vs +20.1%/yr prior
5Y CAGR
-1.7%/yr
Recent deceleration
Acceleration
-49.2pp
Decelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $4.23B | -1.2% |
| 2024 | $4.28B | -12.0% |
| 2023 | $4.86B | -58.9% |
| 2022 | $11.84B | +2.5% |
| 2021 | $11.54B | +150.0% |
| 2020 | $4.62B | -41.4% |
| 2019 | $7.88B | +38.6% |
| 2018 | $5.69B | +7.1% |
| 2017 | $5.31B | -10.8% |
| 2016 | $5.95B | - |